Kailera Therapeutics: Insider Ownership Change Reported
Ticker: KLRA · Form: 4 · Filed: Apr 20, 2026 · CIK: 0002096997
Sentiment: neutral
Topics: insider-filing, ownership-change
TL;DR
Kailera Therapeutics insider Adam Koppel filed a Form 4 on ownership changes.
AI Summary
On April 16, 2026, Adam Koppel reported a change in beneficial ownership of securities for Kailera Therapeutics, Inc. The filing, a Form 4, was accepted by the SEC on April 20, 2026. Specific details regarding the nature of the transaction and the number of shares involved are not provided in this summary document.
Why It Matters
This filing indicates a change in the holdings of an insider, which can sometimes signal shifts in confidence or strategy regarding the company's stock.
Risk Assessment
Risk Level: low — Form 4 filings report routine changes in beneficial ownership and do not inherently indicate significant risk without further context.
Key Players & Entities
- Adam Koppel (person) — Reporting person
- Kailera Therapeutics, Inc. (company) — Issuer
- 2026-04-16 (date) — Period of report
- 2026-04-20 (date) — Filing date
FAQ
Who is the reporting person for this Form 4 filing?
Adam Koppel is the reporting person.
What is the name of the issuer company?
The issuer company is Kailera Therapeutics, Inc.
What type of SEC filing is this?
This is a Form 4 filing, a Statement of changes in beneficial ownership of securities.
When was the period of report for this transaction?
The period of report was April 16, 2026.
When was this Form 4 filing accepted by the SEC?
The filing was accepted on April 20, 2026.
Filing Details
This Statement of Changes in Beneficial Ownership (Form 4) was filed with the SEC on April 20, 2026 by Adam Koppel regarding Kailera Therapeutics, Inc. (KLRA). Form 4 filings disclose purchases, sales, or other changes in ownership by company insiders such as officers, directors, and major shareholders.